Location History:
- Tuebingen, DE (2007 - 2015)
- Tubingen, DE (2015)
Company Filing History:
3 out of 16 
2 out of 4,943 
1 out of 2 Years Active: 2007-2015
Title: The Innovations of Hans-Joerg Buehring
Introduction
Hans-Joerg Buehring is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of stem cell research and antibody development. With a total of six patents to his name, Buehring's work has the potential to impact medical treatments significantly.
Latest Patents
One of his latest patents focuses on the isolation and/or identification of stem cells with adipocytic, chondrocytic, and pancreatic differentiation potential. This invention involves a method that utilizes an antibody binding to the antigen TNAP, either alone or in combination with an antibody that binds to the cell surface antigen CD56. The stem cells isolated through this method are intended for treating defects, damages, or diseases in bone or cartilage. Another significant patent involves anti-FLT3 antibodies with a modified Fc region, which includes amino acid substitutions 239D and 332E. This modification enhances the antibody-dependent cell cytotoxicity (ADCC) of these antibodies. The invention also encompasses pharmaceutical compositions containing these antibodies, nucleic acids encoding them, and methods for their use.
Career Highlights
Buehring has worked at several prestigious institutions, including Eberhard Karls University of Tuebingen and Universitätsklinikum Tübingen. He has also been associated with Hoffmann-La Roche Inc., where he contributed to various research initiatives.
Collaborations
Some of his notable coworkers include Reiner Lammers and Selim Kuci, who have collaborated with him on various projects.
Conclusion
Hans-Joerg Buehring's innovative work in stem cell research and antibody development showcases his significant contributions to medical science. His patents reflect a commitment to advancing healthcare solutions through scientific research and innovation.